KNOXVILLE, TN, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- Daisy Genomics Inc. (“Daisy Genomics”) and New Day ...
Tecentriq, Avastin Regimen Beats Anti-PD-L1 Monotherapy in MMR-Deficient, MSI-High Colorectal Cancer
Genentech's PD-L1 inhibitor combined with Avastin and chemo improved median progression-free survival by around 20 months ...
Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...
Chicago-based Northwestern Medicine has built one of the country’s most ambitious transplant programs. Whether performing the first double lung-liver transplant in the U.S., eliminating all traces of ...
Regular walking during recovery may reduce cancer-related fatigue and improve long-term well-being for patients with ...
New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.
Jonathan Bricker, PhD, and Fred Hutch’s Health and Behavioral Innovations in Technology (HABIT) research group developed an AI-powered chatbot app called QuitBot to help more people successfully quit ...
Millions remain unscreened for colorectal cancer. Learn how noninvasive screening can expand access, preserve capacity, and ...
A recent study revealed that regular physical activity, particularly walking, can minimise fatigue in people with colon ...
Introduction Each year, millions of people experience recurrent diverticulitis episodes. Elective sigmoid colon resection reduces the risk of recurrence, but The American Society of Colon and Rectal ...
Exelixis teamed with Natera on the phase III STELLAR-316 study testing zanzalintinib in resected stage II/III colorectal cancer. Stock gains.
New Medicaid eligibility rules may cause more than a million missed cancer screenings, and more than 100 preventable deaths, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback